Subscribe
8 December 2017Biotechnology

English court sides with Eli Lilly in Genentech jurisdictional clash

The English High Court has sided with Eli Lilly in holding that its UK-related claims in a patent case can be heard together with its European-based arguments in the UK.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
Taiwanese biotech built on ‘foundation of lies’, says DoJ
8 July 2021   US prosecutors have charged the founders of Taiwanese biosimilar manufacturer JHL Biotech with stealing Genentech trade secrets.
Americas
Genentech hits Eli Lilly with skin treatment claim
4 July 2018   Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Generics
Taiwanese biotech built on ‘foundation of lies’, says DoJ
8 July 2021   US prosecutors have charged the founders of Taiwanese biosimilar manufacturer JHL Biotech with stealing Genentech trade secrets.
Americas
Genentech hits Eli Lilly with skin treatment claim
4 July 2018   Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.

More on this story

Generics
Taiwanese biotech built on ‘foundation of lies’, says DoJ
8 July 2021   US prosecutors have charged the founders of Taiwanese biosimilar manufacturer JHL Biotech with stealing Genentech trade secrets.
Americas
Genentech hits Eli Lilly with skin treatment claim
4 July 2018   Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler